Last month’s federal budget risks doing real damage to Australia’s ability to commercialise medical research, even as it gets part of the equation right. The increased distribution from the Medical...
CSL, Cochlear, and Gardasil are all great Australian biotech success stories; we have done it before. How do we do it again and again? With the $20 billion Medical...